Panacea Biotec Limited — Others, 26-12-2024: Trading Window

Panacea Biotec has announced a board meeting to approve the financial results for the quarter and nine months ending December 31, 2024. The trading window for the company's designated persons will remain closed from January 1, 2025, until 48 hours after the results are announced. This closure aims to prevent insider trading activities, maintaining compliance and protecting shareholder interests. Investors should view this as a standard practice that ensures transparency and fair trading, potentially fostering a positive outlook amidst the upcoming financial disclosures.